Both in Biotechnology
Dyadic International vs aTyr Pharma
Over the past year DYAI returned −65.1% and ATYR returned −81.3%; their daily moves had a correlation of 0.10.
DYAI −65.1% ATYR −81.3%Growth of $1, one year, split-adjusted
| Metric | DYAI | ATYR |
|---|---|---|
| Price | $0.3667 | $6.18 |
| Market cap | $14.7M | $15.4M |
| Today | +1.86% | −6.79% |
| 1 month | −19.1% | −45.5% |
| 6 months | −51.8% | −85.1% |
| Year to date | −61.0% | −80.3% |
| 1 year | −66.0% | −82.5% |
| Revenue growth (YoY) | −0.6% | — |
| Gross margin | −2.4% | — |
| Net margin | −221.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.9× | 81.3× |
| Net cash | -$1.9M | $56.9M |
| Dividend yield | — | — |
| Volatility (60d) | 76.8% | 1,072.3% |
| Short % of float | 0.7% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).